In the realm of immunology research, the use of specialized animal models has been transformative for understanding cellular responses. Among these, the 2D2 mice MOG peptide model stands out as a critical tool for scientists investigating T cell receptor (TCR) dynamics. My journey into exploring these models has revealed how specific genetic modifications can provide deep insights in MOG Disease and Treatments | Mass General Brigham to how immune cells interact with myelin oligodendrocyte glycoprotein (MOG).
The Foundation: What are 2D2 Mice?
The 2D2 TCR (TCR MOG) transgenic mice are a cornerstone of modern immunology. These mice are engineered on a C57BL/6 background to express a specifi Oct 12, 2023—The transgenic 2D2 mice have a population of T cells bearing myelinoligodendrocyte glycoprotein (MOG)35–55-specific T cell receptors (TCRs).Read more c TCR that recognizes the MOG35–55 peptide (MEVGWYRSPFSRVVHLYRNGK). by E Bettelli·2003·Cited by 1094—In this report, we describe the generation of a TCR transgenic mouse (2D2) specific for theMOG35–55peptideon the C57Bl/6 background. A large proportion of Read more When we look at the 2D2 MOG-specific T cell receptor (TCR) mice, we are essentially looking at a controlled system where a significant population of CD4+ T Memory cells specific for myelin oligodendrocyte glycoprotein cells is primed to respond to a single, well-defined antigen.
From my review of the literature, it is fascinating to see how 2D2 mice serve as a reliable source of T cells for *in vitro* studies. Researchers often use 2D2 cells stimulated with MOG to observe how these speci Research indicates that theseMOG-specific B cells and antibodies can activate effector T cells via antigen-presenting cells within the central nervous system.Read more fic T cells behave in a controlled environment. A consistent finding across various studies is that 2D2 CD4+ T cell stimulation with MOG results in delayed expression of activation markers, which provides a unique window into the kinetics of T cell signaling and activation thresholds.
Immunization and Experimental Outcomes
A common practice in this field is the immunization of these subjects. 2D2 mice were immunized with MOG35–55 to study immune activation. It is well-documented that 2D2 mice exhibit early onset EAE following immunization with MOG35–55 compared to wild-type counterparts. This early onset is a direct consequence of the high frequency of MOG-specific T cells present in the transgenic model.
Furthermore, the interaction b C57BL/6-Tg(Tcra2D2,Tcrb2D2)1Kuch/J etween different immune components is vital. For example, the transfer of anti-MOG antibodies into 2D2 mice has been shown to trigger spontaneous responses, highlighting the synergistic role of B cells and T cells in this model. When discussing MOG T cell receptor transgenic 2D2 mice, it is impossible to ignore the role of the peptide MOG itself. Whether using the synthetic 35–55 sequence or recombinant proteins, the precision with which these MOG peptides are used defines the reproducibility of the data.
The Role of Novel Therapies and Observations
The versatility of this model extends to the testing of potential therapeutic interventions. For instance, studies involving OM-MOG reversed clinical symptoms in various experimental settings, showing that the modulation of the immune response is possible even in models with high antigen specificity.
When analyzing 2D2 subjects, researchers must consider the age-dependent effects and the environmental context. Whether studying MOG mice in the context of spontaneous disease development or using them for peptide stimulation a by L Blanchfield·2017·Cited by 8—6×105primed lymph node cells or naïve2D2splenocytes were cultured in a 96-well flat bottom plate with indicatedpeptidesand concentrations. After 48 hours, Read more ssays, the model remains a robust, albeit specialized, entity.
Why This Research Matters
The use of 2D2 models allows for a granular view of the immune system that would be impossible to achieve otherwise. By focusing on the 2D2 TCR, investigators can track specific cell populations and their interactions with MOG in real-time. The precision of the peptide used—specifically the 35–55 sequence—ensures that the 2D2 model remains the gold standard for studies focusing on the specificity of T cell responses.
In summary, the 2D2 mice MOG peptide system is an indispensable asset for understanding the nuances of antigen-specific immune activation. Through the careful study of 2D2 cells stimulated with MOG and the longitudinal observation of 2D2 mice, the sci NFM cross-reactivity to MOG does not expand a critical - PMC entific community continues to gain clarity on the complex signaling cascades that govern immune cell behavior. Whether analyzing the impact of MOG peptides or evaluating new molecules like OM-MOG, this model provides the clarity and control necessary to push the boundaries of immunological science.